2m 2m 2m 2m 2m 2m 2m
AETHLON MEDICAL (AEMD)
NASDAQ
$2.09-$0.12 (-5.52%)
Price as of Jun 03, 2026 7:15 PM EDT- $3.5MMarket Cap
- -92.11%1-Year Change
- Medical DevicesIndustry
AETHLON MEDICAL (AEMD)
$2.09-$0.12 (-5.52%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 0 -100.00% | 574,245 +95.21% | 294,165 -55.37% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 574,245 +95.21% | 294,165 -55.37% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -2.2M -12.22% | -2.5M -8.20% | -2.7M +17.26% | -2.3M +12.98% | |
Depreciation and Amortization Expense | 339,559 -5.43% | 359,057 +49.05% | 240,892 +94.76% | 123,685 +209.68% | |
Total Operating Expenses | 9.3M -26.08% | 12.6M +1.31% | 12.5M +16.41% | 10.7M +25.34% | |
Operating Profit | -9.3M -26.08% | -12.6M +6.20% | -11.9M +14.18% | -10.4M +32.08% | |
Interest Income | 324,450 -24.26% | 428,394 +3,804.07% | 10,973 N/A | N/A N/A | |
Interest Expense | -10,109 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 314,341 -26.62% | 428,394 +3,804.07% | 10,973 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 298,122 N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -9.3M -26.08% | -12.6M +6.20% | -11.9M +14.18% | -10.4M +32.08% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -13.4M +9.75% | -12.2M +1.48% | -12.0M +15.49% | -10.4M +32.07% | |
Net Income from Continuing Operations Applicable to Common | N/A N/A | -12.2M +1.48% | -12.0M +15.49% | -10.4M +32.07% | |
Basic EPS and Net Income | -8.58 +76.54% | -4.86 +723.73% | -0.59 N/A | N/A N/A | |
Diluted EPS and Net Income | -8.58 +76.54% | -4.86 +723.73% | -0.59 N/A | N/A N/A | |
Basic Weighted Average Shares | 1.6M -37.88% | 2.5M -87.76% | 20.5M +39.17% | 14.8M +22.05% | |
Diluted Weighted Average Shares | 1.6M -37.88% | 2.5M -87.76% | 20.5M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.5M +1.09% | 5.4M -62.55% | 14.5M -14.87% | 17.1M +73.12% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.5M +1.09% | 5.4M -62.55% | 14.5M -14.87% | 17.1M +73.12% | |
Total Current Assets | 5.9M -4.43% | 6.2M -58.74% | 15.1M -16.89% | 18.2M +75.40% | |
Accumulated Depreciation | 978,889 -1.18% | 990,550 +34.91% | 734,207 +48.67% | 493,864 +16.22% | |
Property and Plant and Equipment and Net | 676,220 -33.39% | 1.0M -11.26% | 1.1M +159.27% | 441,238 +174.10% | |
Total Long-Term Assets | 676,220 -47.70% | 1.3M +13.03% | 1.1M +159.27% | 441,238 +174.10% | |
Total Assets | 7.4M -10.75% | 8.2M -52.90% | 17.5M -9.83% | 19.4M +82.00% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 155,742 +31.41% | |
Total Current Liabilities | 1.9M +3.79% | 1.8M +21.58% | 1.5M -17.49% | 1.8M +32.64% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 336,718 -48.18% | 649,751 -30.85% | 939,642 +55.96% | 602,505 N/A | |
Total Liabilities | 2.2M -9.83% | 2.5M +1.43% | 2.4M +0.75% | 2.4M +76.45% | |
Retained Earnings | -168.0M +8.66% | -154.6M +8.58% | -142.4M +9.23% | -130.3M +8.69% | |
Total Stockholders Equity | 5.1M -11.15% | 5.8M -61.72% | 15.1M -12.08% | 17.1M +81.68% | |
Total Shares Outstanding | 2.0M -23.54% | 2.6M -88.56% | 23.0M +49.12% | 15.4M +26.90% | |
Cash Flow | |||||
Cash from Operating Activities | -7.6M -24.52% | -10.1M -3.57% | -10.5M +7.56% | -9.8M +44.38% | |
Capital Expenditures | 0 -100.00% | 250,867 -73.40% | 943,109 +170.08% | 349,193 +483.14% | |
Cash from Investing Activities | 0 +100.00% | -250,867 -73.40% | -943,109 +170.08% | -349,193 +483.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.7M +500.14% | 1.3M -85.56% | 8.9M -48.67% | 17.4M +143.65% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | -2,072.05% -41.51% | -3,542.53% +195.93% | |
Return on Assets | -171.71% +81.13% | -94.80% +45.50% | -65.15% -5.90% | -69.24% -7.57% | |
Return on Equity | -246.07% +109.93% | -117.21% +56.86% | -74.73% -4.72% | -78.42% -6.33% | |
Revenue Growth | N/A N/A | -100.00% -205.03% | 95.21% +271.96% | -55.37% -4,137.11% | |
Current Ratio | 3.13 -7.92% | 3.40 -66.07% | 10.03 +0.73% | 9.95 +32.24% | |
Cash Ratio | 2.90 -2.60% | 2.97 -69.20% | 9.66 +3.17% | 9.36 +30.52% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow